EMR-P for small rectal neuroendocrine tumors: is it a preferred treatment?

Zhaohui Liua The Department of Gastroenterology, Shenzhen Second People’s Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China

Chunsi Zhenga The Department of Gastroenterology, Shenzhen Second People’s Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China

Shihua Dinga The Department of Gastroenterology, Shenzhen Second People’s Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China

Chong Chena The Department of Gastroenterology, Shenzhen Second People’s Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China

Jingbo Yanga The Department of Gastroenterology, Shenzhen Second People’s Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China

Ruinuan Wub The Department of Pathology, Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, ChinaCorrespondence[email protected]

Dayong Suna The Department of Gastroenterology, Shenzhen Second People’s Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, ChinaCorrespondence[email protected]

show all

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

EMR-P for small rectal neuroendocrine tumors: is it a preferred treatment?

Articles from other publishers (3)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

EMR-P for small rectal neuroendocrine tumors: is it a preferred treatment?

Citations (3)

Articles from other publishers (3)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date